US BANCORP \DE\ - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 21 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$4,000
+33.3%
2,0000.0%0.00%
Q1 2022$3,0000.0%2,0000.0%0.00%
Q4 2021$3,000
-50.0%
2,0000.0%0.00%
Q3 2021$6,000
-40.0%
2,0000.0%0.00%
Q2 2021$10,000
+400.0%
2,000
+100.0%
0.00%
Q4 2020$2,000
+100.0%
1,000
+60.0%
0.00%
Q3 2020$1,0000.0%6250.0%0.00%
Q2 2020$1,0000.0%6250.0%0.00%
Q1 2020$1,0006250.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2020
NameSharesValueWeighting ↓
WealthTrust Axiom LLC 11,561$21,0000.01%
Tower Research Capital LLC (TRC) 38,887$73,0000.00%
Newbridge Financial Services Group, Inc. 312$1,0000.00%
Stonebridge Financial Planning Group, LLC 375$1,0000.00%
Squarepoint Ops LLC 15,680$29,0000.00%
OSAIC HOLDINGS, INC. 808$1,0000.00%
US BANCORP \DE\ 1,000$2,0000.00%
WELLS FARGO & COMPANY/MN 86$00.00%
NORTHERN TRUST CORP 16,192$30,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders